Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01921426Phase 1Completed
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Pogorzelski, Dr.

Universitätsklinikum Essen

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Christine H. Chung, M.D.

H. Lee Moffitt Cancer Center and Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Rainer Fietkau, Prof

Universitätsklinikum Erlangen, Radiation Oncology

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Victor Grünwald, Prof. Dr.

Universitätsklinikum Essen

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Etta Pisano, MD

American College of Radiology

Moderately Similar
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Sarina Müller, PD

Universitätsklinikum Erlangen, HNO

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Similarity Score30%

Aftab Mahmood, MD

Cancer Specialists of South Texas, P.A.

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx

Worked with same sponsors:

Galera Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score24%

Pardip Pathare, MD

Norwalk Hospital

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx

Worked with same sponsors:

Galera Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score24%

Douglas Adkins, MD

Washington University School of Medicine

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx

Worked with same sponsors:

Galera Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score24%

Madhavi Venigalla, MD

Lakeland Regional Cancer Center

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx

Worked with same sponsors:

Galera Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01921426Phase 1PrincipalInvestigator

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Oropharynx
Completed

All 1 trials loaded